Salonia A, Rastrelli G, Hackett G, Seminara SB, Huhtaniemi IT, Rey RA, et al. Paediatric and adult-onset male hypogonadism. Nat Rev Dis Primers. 2019;5:38.

PubMed  PubMed Central  Google Scholar 

Wu FCW, Tajar A, Beynon JM, Pye SR, Silman AJ, Finn JD, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 2010;363:123–35.

CAS  PubMed  Google Scholar 

Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract. 2006;60:762–9.

CAS  PubMed  Google Scholar 

Zarotsky V, Huang MY, Carman W, Morgentaler A, Singhal PK, Coffin D, et al. Systematic literature review of the risk factors, comorbidities, and consequences of hypogonadism in men. Andrology. 2014;2:819–34.

CAS  PubMed  Google Scholar 

Maggi M, Schulman C, Quinton R, Langham S, Uhl-Hochgraeber K. The burden of testosterone deficiency syndrome in adult men: economic and quality-of-life impact. J Sex Med. 2007;4:1056–69.

PubMed  Google Scholar 

Grinspon RP. Genetics of congenital central hypogonadism. Best Pract Res Clin Endocrinol Metab. 2022;36:101599.

CAS  PubMed  Google Scholar 

Chiles KA. Hypogonadism and erectile dysfunction as harbingers of systemic disease. Transl Androl Urol. 2016;5:195–200.

PubMed  PubMed Central  Google Scholar 

Choi EJ, Xu P, El-Khatib FM, Huynh LM, Yafi FA. Hypogonadism and its treatment among prostate cancer survivors. Int J Impot Res. 2021;33:480–7.

PubMed  Google Scholar 

Gonzalez-Daza SJ, Díaz-Hung AM, García-Perdomo HA. Association between varicocele and hypogonadism, or erectile dysfunction: a systematic review and meta-analysis. Actas Urol Esp. 2024;48:751–9.

CAS  PubMed  Google Scholar 

Spruit MA, Thomeer MJ, Gosselink R, Wuyts WA, Van Herck E, Bouillon R, et al. Hypogonadism in male outpatients with sarcoidosis. Respir Med. 2007;101:2502–10.

PubMed  Google Scholar 

Singh J, Sahoo AK, Swain J, Mangaraj S, Kanwar JB, Manglunia A. Assessment of hypogonadism and its determinants among adult men with type 2 diabetes mellitus. Prim Care Diabetes. 2023;17:348–53.

CAS  PubMed  Google Scholar 

Finas D, Bals-Pratsch M, Sandmann J, Eichenauer R, Jocham D, Diedrich K, et al. Quality of life in elderly men with androgen deficiency. Andrologia. 2006;38:48–53.

CAS  PubMed  Google Scholar 

Aydogan U, Aydogdu A, Akbulut H, Sonmez A, Yuksel S, Basaran Y, et al. Increased frequency of anxiety, depression, quality of life and sexual life in young hypogonadotropic hypogonadal males and impacts of testosterone replacement therapy on these conditions. Endocr J. 2012;59:1099–105.

PubMed  Google Scholar 

Boloña ER, Uraga MV, Haddad RM, Tracz MJ, Sideras K, Kennedy CC, et al. Testosterone use in men with sexual dysfunction: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc. 2007;82:20–8.

PubMed  Google Scholar 

Traish AM. Major cardiovascular disease risk in men with testosterone deficiency (hypogonadism): appraisal of short, medium and long-term testosterone therapy - a narrative review. Sex Med Rev. 2023;11:384–94.

PubMed  Google Scholar 

Yassin DJ, Doros G, Hammerer PG, Yassin AA. Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life. J Sex Med. 2014;11:1567–76.

CAS  PubMed  Google Scholar 

Thirumalai A, Anawalt BD. Epidemiology of male hypogonadism. Endocrinol Metab Clin North Am. 2022;51:1–27.

PubMed  PubMed Central  Google Scholar 

Rey RA, Grinspon RP, Gottlieb S, Pasqualini T, Knoblovits P, Aszpis S, et al. Male hypogonadism: an extended classification based on a developmental, endocrine physiology-based approach. Andrology. 2013;1:3–16.

CAS  PubMed  Google Scholar 

Kumar P, Kumar N, Thakur DS, Patidar A. Male hypogonadism: symptoms and treatment. J Adv Pharm Technol Res. 2010;1:297–301.

PubMed  PubMed Central  Google Scholar 

Chueh KS, Huang SP, Lee YC, Wang CJ, Yeh HC, Li WM, et al. The comparison of the aging male symptoms (AMS) scale and androgen deficiency in the aging male (ADAM) questionnaire to detect androgen deficiency in middle-aged men. J Androl. 2012;33:817–23.

CAS  PubMed  Google Scholar 

Salonia A, Boeri L, Capogrosso P, Corona G, Dinkelman-Smith M, Falcone M, et al. EAU guidelines on sexual and reproductive health. Eur Urol. 2025;88:76–102.

PubMed  Google Scholar 

Jayasena CN, Anderson RA, Llahana S, Barth JH, MacKenzie F, Wilkes S, et al. Society for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism. Clin Endocrinol. 2022;96:200–19.

Google Scholar 

Mulhall JP, Trost LW, Brannigan RE, Kurtz EG, Redmon JB, Chiles KA, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200:423–32.

PubMed  Google Scholar 

Hackett G, Kirby M, Rees RW, Jones TH, Muneer A, Livingston M, et al. The british society for sexual medicine guidelines on male adult testosterone deficiency, with statements for practice. World J Mens Health. 2023;41:508–37.

PubMed  PubMed Central  Google Scholar 

Dean JD, McMahon CG, Guay AT, Morgentaler A, Althof SE, Becher EF, et al. The international society for sexual medicine’s process of care for the assessment and management of testosterone deficiency in adult men. J Sex Med. 2015;12:1660–86.

CAS  PubMed  Google Scholar 

Corona G, Goulis DG, Huhtaniemi I, Zitzmann M, Toppari J, Forti G, et al. European academy of andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males: endorsing organization: European society of endocrinology. Andrology. 2020;8:970–87.

PubMed  Google Scholar 

Isidori AM, Aversa A, Calogero A, Ferlin A, Francavilla S, Lanfranco F, et al. Adult- and late-onset male hypogonadism: the clinical practice guidelines of the Italian Society of Andrology and Sexual Medicine (SIAMS) and the Italian Society of Endocrinology (SIE). J Endocrinol Invest. 2022;45:2385–403.

CAS  PubMed  PubMed Central  Google Scholar 

Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, et al. Testosterone therapy in men with hypogonadism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2018;103:1715–44.

PubMed  Google Scholar 

Araujo AB, Dixon JM, Suarez EA, Murad MH, Guey LT, Wittert GA. Clinical review: endogenous testosterone and mortality in men: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2011;96:3007–19.

CAS  PubMed  PubMed Central  Google Scholar 

Araujo AB, O’Donnell AB, Brambilla DJ, Simpson WB, Longcope C, Matsumoto AM, et al. Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 2004;89:5920–6.

CAS  PubMed  Google Scholar 

Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab. 2001;86:724–31.

CAS  PubMed  Google Scholar 

Grossmann M, Matsumoto AM. A perspective on middle-aged and older men with functional hypogonadism: focus on holistic management. J Clin Endocrinol Metab. 2017;102:1067–75.

PubMed  PubMed Central  Google Scholar 

Tajar A, Forti G, O’Neill TW, Lee DM, Silman AJ, Finn JD, et al. Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. J Clin Endocrinol Metab. 2010;95:1810–8.

CAS  PubMed  Google Scholar 

Araujo AB, Esche GR, Kupelian V, O’Donnell AB, Travison TG, Williams RE, et al. Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab. 2007;92:4241–7.

CAS  PubMed  Google Scholar